β adrenergic signaling regulates hematopoietic stem and progenitor cell commitment and therapy sensitivity in multiple myeloma

Haematologica. 2022 Sep 1;107(9):2226-2231. doi: 10.3324/haematol.2022.280907.
No abstract available

MeSH terms

  • Adrenergic Agents
  • Hematopoietic Stem Cells
  • Humans
  • Multiple Myeloma* / therapy

Substances

  • Adrenergic Agents